163 related articles for article (PubMed ID: 27595116)
1. Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma.
Lu Z; Peng K; Wang N; Liu HM; Hou G
J Immunol Res; 2016; 2016():7828916. PubMed ID: 27595116
[TBL] [Abstract][Full Text] [Related]
2. [Sensitivity of esophageal squamous cell carcinoma cells to rapamycin can be improved by siRNA-interfered expression of p70S6K].
Liu M; Lu Z; Zheng Y; Cui Y; Wang J; Hou G
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):885-9. PubMed ID: 26887615
[TBL] [Abstract][Full Text] [Related]
3. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR.
Hou G; Xue L; Lu Z; Fan T; Tian F; Xue Y
Cancer Lett; 2007 Aug; 253(2):236-48. PubMed ID: 17360108
[TBL] [Abstract][Full Text] [Related]
4. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.
Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z
Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma.
Li SH; Chen CH; Lu HI; Huang WT; Tien WY; Lan YC; Lee CC; Chen YH; Huang HY; Chang AY; Lin WC
Surgery; 2015 Mar; 157(3):570-80. PubMed ID: 25726316
[TBL] [Abstract][Full Text] [Related]
6. Wild-type phosphatase and tensin homolog deleted on chromosome 10 improved the sensitivity of cells to rapamycin through regulating phosphorylation of Akt in esophageal squamous cell carcinoma.
Lu Z; Wang J; Zheng Y; Yang S; Liu M; Chen X; Wang C; Hou G
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26725440
[TBL] [Abstract][Full Text] [Related]
7. [Effects of mTOR siRNA on mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cells and the growth of transplanted tumor in nude mice].
Liu MY; Hou GQ; Zhang Y; Bei WJ; Yan AH
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):334-9. PubMed ID: 21875460
[TBL] [Abstract][Full Text] [Related]
8. Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro.
Li Q; Yang L; Han K; Zhu L; Zhang Y; Ma S; Zhang K; Yang B; Guan F
Oncotarget; 2016 Sep; 7(38):61458-61468. PubMed ID: 27556183
[TBL] [Abstract][Full Text] [Related]
9. Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice.
Liu Y; Wang X; Jia Y; Liu Y
Int J Mol Med; 2017 Aug; 40(2):357-366. PubMed ID: 28656204
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE
Pun IH; Chan D; Chan SH; Chung PY; Zhou YY; Law S; Lam AK; Chui CH; Chan AS; Lam KH; Tang JC
Cancer Res Treat; 2017 Jan; 49(1):219-229. PubMed ID: 27456944
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
[TBL] [Abstract][Full Text] [Related]
13. [Expression of IGF-1R in esophageal squamous cell carcinoma and the effect of its silencing by siRNA on the proliferation of esophageal cancer EC9706 cells in vitro].
Ma W; Li W; Fan QX; Wang LX; Wang RL; Lu SX
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):609-12. PubMed ID: 22325222
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of mTOR signaling improves sensitivity of esophageal squamous cell carcinoma cells to cisplatin.
Hou G; Yang S; Zhou Y; Wang C; Zhao W; Lu Z
J Immunol Res; 2014; 2014():845763. PubMed ID: 24818169
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
16. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
Wang F; Ding X; Wang T; Shan Z; Wang J; Wu S; Chi Y; Zhang Y; Lv Z; Wang L; Fan Q
PLoS One; 2017; 12(4):e0174276. PubMed ID: 28406985
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling.
Liu X; Yan Y; Ma W; Wu S
Biochem Biophys Res Commun; 2017 Aug; 490(3):1112-1118. PubMed ID: 28669726
[TBL] [Abstract][Full Text] [Related]
20. Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma.
Gong F; Hou G; Liu H; Zhang M
Med Oncol; 2015 Feb; 32(2):455. PubMed ID: 25579166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
